SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001140361-19-003636
Filing Date
2019-02-21
Accepted
2019-02-21 16:16:35
Documents
59
Period of Report
2018-12-31

Document Format Files

Seq Description Document Type Size
1 10-K form10k.htm 10-K 1713792
2 EXHIBIT 23.1 ex23_1.htm EX-23.1 3362
3 EXHIBIT 31.1 ex31_1.htm EX-31.1 16519
4 EXHIBIT 31.2 ex31_2.htm EX-31.2 16515
5 EXHIBIT 32.1 ex32_1.htm EX-32.1 6533
6 EXHIBIT 32.2 ex32_2.htm EX-32.2 6578
  Complete submission text file 0001140361-19-003636.txt   5592183

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT edge-20181231.xml EX-101.INS 770714
8 XBRL TAXONOMY EXTENSION SCHEMA edge-20181231.xsd EX-101.SCH 39800
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE edge-20181231_cal.xml EX-101.CAL 52482
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE edge-20181231_def.xml EX-101.DEF 217177
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE edge-20181231_lab.xml EX-101.LAB 686825
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE edge-20181231_pre.xml EX-101.PRE 364740
Mailing Address 300 CONNELL DRIVE SUITE 4000 BERKELEY HEIGHTS NJ 07922
Business Address 300 CONNELL DRIVE SUITE 4000 BERKELEY HEIGHTS NJ 07922 800-208-3343
Edge Therapeutics, Inc. (Filer) CIK: 0001472091 (see all company filings)

IRS No.: 264231384 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-37568 | Film No.: 19622073
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences